| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2022 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R44OD024964 | Pan-specific tools and reagents for the enrichment of sialo-glycans | 001 | 3 | NIH | 12/18/2022 | $0 |
| | 2023 | 2021 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R44OD024964 | Pan-specific tools and reagents for the enrichment of sialo-glycans | 000 | 3 | NIH | 12/17/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $37,199 ) |
| | 2022 | 2022 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R44OD024964 | Pan-specific tools and reagents for the enrichment of sialo-glycans | 000 | 3 | NIH | 8/19/2022 | $37,200 |
| | 2022 | 2020 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R44GM113351 | High-specificity affinity reagents for the detection of glycan sialylation | 000 | 5 | NIH | 8/1/2022 | $0 |
| | 2022 | 2019 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | U01CA221213 | Adapting multiplex microspheres to analyze glycosylation features by flow cytometry | 000 | 3 | NIH | 12/8/2021 | -$1 |
|
| Issue Date FY: 2021 ( Subtotal = $1,188,370 ) |
| | 2021 | 2021 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R44OD024964 | Pan-specific tools and reagents for the enrichment of sialo-glycans | 000 | 3 | NIH | 3/17/2021 | $740,575 |
| | 2021 | 2021 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R43GM135984 | Development of a suite of high-specificity fucose binding reagents | 000 | 2 | NIH | 2/26/2021 | $225,000 |
| | 2021 | 2021 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R43GM136013 | Novel Reagents for Monitoring Sulfation Patterns in Heparin and Heparan Sulfate | 000 | 2 | NIH | 2/15/2021 | $222,795 |
| | 2021 | 2018 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R43GM123856 | Reagents specific for all N-glycans | 000 | 2 | NIH | 6/27/2021 | $0 |
| | 2021 | 2018 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R44OD024964 | Pan-specific tools and reagents for the enrichment of sialo-glycans | 001 | 1 | NIH | 9/5/2021 | $0 |
| | 2021 | 2018 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R43GM123863 | A rapid method for monitoring in vitro glycoengineering | 000 | 2 | NIH | 2/6/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,540,566 ) |
| | 2020 | 2020 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R43GM136013 | Novel Reagents for Monitoring Sulfation Patterns in Heparin and Heparan Sulfate | 000 | 1 | NIH | 1/23/2020 | $224,996 |
| | 2020 | 2020 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R43GM135984 | Development of a suite of high-specificity fucose binding reagents | 000 | 1 | NIH | 1/10/2020 | $225,000 |
| | 2020 | 2020 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R44GM113351 | High-specificity affinity reagents for the detection of glycan sialylation | 000 | 5 | NIH | 1/15/2020 | $349,995 |
| | 2020 | 2020 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R44OD024964 | Pan-specific tools and reagents for the enrichment of sialo-glycans | 000 | 2 | NIH | 3/17/2020 | $740,575 |
| | 2020 | 2019 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R43GM123856 | Reagents specific for all N-glycans | 001 | 2 | NIH | 6/25/2020 | $0 |
| | 2020 | 2018 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R43GM123856 | Reagents specific for all N-glycans | 000 | 2 | NIH | 6/24/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $683,732 ) |
| | 2019 | 2019 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R44GM113351 | High-specificity affinity reagents for the detection of glycan sialylation | 000 | 4 | NIH | 12/24/2018 | $349,932 |
| | 2019 | 2019 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R43GM123856 | Reagents specific for all N-glycans | 000 | 2 | NIH | 3/25/2019 | $55,000 |
| | 2019 | 2019 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | U01CA221213 | Adapting multiplex microspheres to analyze glycosylation features by flow cytometry | 001 | 3 | NIH | 7/12/2019 | $278,800 |
| | 2019 | 2018 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | U01CA221213 | Adapting multiplex microspheres to analyze glycosylation features by flow cytometry | 000 | 2 | NIH | 4/30/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $1,228,658 ) |
| | 2018 | 2018 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R43GM123856 | Reagents specific for all N-glycans | 000 | 2 | NIH | 7/20/2018 | $224,944 |
| | 2018 | 2018 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R44OD024964 | Pan-specific tools and reagents for the enrichment of sialo-glycans | 000 | 1 | NIH | 8/23/2018 | $224,934 |
| | 2018 | 2018 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | U01CA221213 | Adapting multiplex microspheres to analyze glycosylation features by flow cytometry | 000 | 2 | NIH | 6/26/2018 | $278,800 |
| | 2018 | 2018 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R43GM123863 | A rapid method for monitoring in vitro glycoengineering | 000 | 2 | NIH | 8/28/2018 | $150,000 |
| | 2018 | 2018 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R44GM113351 | High-specificity affinity reagents for the detection of glycan sialylation | 000 | 3 | NIH | 1/10/2018 | $349,980 |
| | 2018 | 2016 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R41GM113351 | High-specificity affinity reagents for the detection of glycan sialylation | 000 | 2 | NIH | 11/27/2017 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $653,744 ) |
| | 2017 | 2017 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R43GM123863 | A rapid method for monitoring in vitro glycoengineering | 000 | 1 | NIH | 9/19/2017 | $150,000 |
| | 2017 | 2017 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R43GM123856 | Reagents specific for all N-glycans | 000 | 1 | NIH | 8/1/2017 | $224,944 |
| | 2017 | 2017 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | U01CA221213 | Adapting multiplex microspheres to analyze glycosylation features by flow cytometry | 000 | 1 | NIH | 7/21/2017 | $278,800 |
| | 2017 | 2015 | GLYCOSENSORS AND DIAGNOSTICS, LLC | 111 RIVERBEND RD | ATHENS | GA | 30602-1514 | CLARKE | USA | R42GM086991 | High-specificity affinity reagents for N-glycosylation site mapping and glycomics | 000 | 4 | NIH | 7/5/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $349,282 ) |
| | 2016 | 2016 | GLYCOSENSORS & DIAGNOSTICS LLC | 250 GREYSTONE TERRACE | ATHENS | GA | 30606 | CLARKE | USA | R41GM113351 | High-specificity affinity reagents for the detection of glycan sialylation | 000 | 2 | NIH | 12/15/2015 | $349,282 |
|
| Issue Date FY: 2015 ( Subtotal = $940,110 ) |
| | 2015 | 2015 | GLYCOSENSORS & DIAGNOSTICS LLC | 250 GREYSTONE TERRACE | ATHENS | GA | 30606 | CLARKE | USA | R42GM086991 | High-specificity affinity reagents for N-glycosylation site mapping and glycomics | 000 | 4 | NIH | 8/20/2015 | $591,235 |
| | 2015 | 2015 | GLYCOSENSORS & DIAGNOSTICS LLC | 250 GREYSTONE TERRACE | ATHENS | GA | 30606 | CLARKE | USA | R41GM113351 | High-specificity affinity reagents for the detection of glycan sialylation | 000 | 1 | NIH | 1/13/2015 | $348,875 |
|
| Issue Date FY: 2014 ( Subtotal = $589,209 ) |
| | 2014 | 2014 | GLYCOSENSORS & DIAGNOSTICS LLC | 250 GREYSTONE TERRACE | ATHENS | GA | 30606 | CLARKE | USA | R42GM086991 | High-specificity affinity reagents for N-glycosylation site mapping and glycomics | 000 | 3 | NIH | 8/21/2014 | $589,209 |
|
| Issue Date FY: 2013 ( Subtotal = $547,745 ) |
| | 2013 | 2013 | GLYCOSENSORS & DIAGNOSTICS LLC | 250 GREYSTONE TERRACE | ATHENS | GA | 30606 | CLARKE | USA | R42GM086991 | High-specificity affinity reagents for N-glycosylation site mapping and glycomics | 000 | 2 | NIH | 9/19/2013 | $547,745 |
|
| Issue Date FY: 2012 ( Subtotal = $99,968 ) |
| | 2012 | 2012 | GLYCOSENSORS & DIAGNOSTICS LLC | 250 GREYSTONE TERRACE | ATHENS | GA | 30606 | CLARKE | USA | R43GM100621 | IN-PROCESS GLYCOPROFILING DURING RECOMBINANT THERAPEUTIC GLYCOPROTEIN PRODUCTION | 000 | 1 | NIH | 9/11/2012 | $99,968 |
|
| Issue Date FY: 2009 ( Subtotal = $200,361 ) (Continued on the next page) |
|
